Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Giorgiutti

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|October 31, 2019
Rat Bite FeverStephane Giorgiutti, Nicolas Lefebvre
Molecular Pharmacology|July 18, 2025
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effectsBirgit Caspar, Nassima Bekaddour, Séverine Grinberg, et al.
Molecular Pharmacology|September 19, 2025
Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055]Birgit Caspar, Nassima Bekaddour, Séverine Grinberg, et al.
Frontiers in Immunology|December 31, 2024
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus modelsNassima Bekaddour, Nikaïa Smith, Birgit Caspar, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|October 31, 2019
Rat Bite FeverStephane Giorgiutti, Nicolas Lefebvre
Molecular Pharmacology|July 18, 2025
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effectsBirgit Caspar, Nassima Bekaddour, Séverine Grinberg, et al.
Molecular Pharmacology|September 19, 2025
Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055]Birgit Caspar, Nassima Bekaddour, Séverine Grinberg, et al.
Frontiers in Immunology|December 31, 2024
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus modelsNassima Bekaddour, Nikaïa Smith, Birgit Caspar, et al.
Pageof 1